Phase 2 Advanced Non-small Cell Lung Cancer (NSCLC) trials recruiting now

All Advanced Non-small Cell Lung Cancer (NSCLC) trials, every phase

Phase 2 Advanced Non-small Cell Lung Cancer (NSCLC) trials

• A Phase II Study of AK146D1 in Combination With AK112 in Advanced Non-Small Cell Lung Cancer
  NCT07669779 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• AMT-116 in Combination With AK112 in Patients With Lung Cancer
  NCT07590531 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Efficacy and Safety of Vorolanib Monotherapy As Third-line or Later Treatment for Advanced Non-small Cell Lung Cancer Patients: a Single-arm, Prospective, Open-label Phase II Clinical Study
  NCT06728852 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers
  NCT07259226 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.